| Français | ISMP (US) | Feedback |
Drug Interaction Pairs Associated with an Increased Likelihood of Hospitalization:
A New Look at the Evidence
January 26, 2011 (at 12 noon ET)
Drug interactions can lead to serious adverse patient outcomes. A number of studies have demonstrated significant associations between specific drug interactions and hospitalizations associated with adverse events.
An important feature of adverse events related to drug interactions is that they are, in theory, largely preventable. In most cases therapeutic alternatives are available so that a significant interaction can be avoided. In practice, however, recognition and management of potential drug interactions is not optimal. Interventions such as electronic screening systems and practitioner education can help, but require proper implementation and oversight to be effective.
A number of population based studies have demonstrated significant associations between specific drug interactions and hospitalizations. This is a new development in determining the clinical impact of specific drug interactions. This one hour webinar will review these studies and discuss some potential strategies in applying the evidence to prevent hospitalizations due to these specific drug interactions.
Learning Objectives:
At the conclusion of this webinar, participants will be able to identify:
- The current approaches to prevention of significant drug interactions;
- Drug interaction pairs shown to be associated with an increased likelihood of hospitalization; and
- Possible strategies to prevent hospitalization due to specific drug interactions.
| Audience: | Pharmacists, nurses, physicians, senior leadership and information systems teams involved in the design and maintenance of drug interaction screening systems in healthcare facilities. |
| Date: | January 26, 2011 |
| Time: |
9:00 am – 10:00 am PT 10:00 am – 11:00 am MT 11:00 am – 12:00 pm CT 12:00 pm – 1:00 pm ET 1:00 pm – 2:00 pm AT 1:30 pm – 2:30 pm NT |
| Duration: | 1 hour |
| Cost: |
$95.00 (for live webinar) per telephone line plus applicable taxes. For registration information, please select the ‘Registration’ tab near the top of the screen. |
| Presenter: |
Roger Cheng, Project Leader, ISMP Canada |
Contact Us: webinars@ismp–canada.org
Speaker(s)
|
Roger Cheng, RPh, BScPhm, PharmD
Roger joined ISMP Canada in 2007. His current responsibilities as a Research Analyst include conducting individual and aggregate analysis from the medication incidents in the ISMP Canada Medication incident database. Roger holds a Bachelor of Science in Pharmacy degree (1999) and a Doctor of Pharmacy degree (2003) from the University of Toronto. Roger has worked in both community and hospital pharmacy settings, including staff pharmacist positions at Princess Margaret Hospital and York Central Hospital. |
Background
Drug interactions can lead to serious adverse patient outcomes. A number of studies have demonstrated significant associations between specific drug interactions and hospitalizations associated with adverse events.
An important feature of adverse events related to drug interactions is that they are, in theory, largely preventable. In most cases therapeutic alternatives are available so that a significant interaction can be avoided. In practice, however, recognition and management of potential drug interactions is not optimal. Interventions such as electronic screening systems and practitioner education can help, but require proper implementation and oversight to be effective.
A number of population based studies have demonstrated significant associations between specific drug interactions and hospitalizations. This is a new development in determining the clinical impact of specific drug interactions. This one hour webinar will review these studies and discuss some potential strategies in applying the evidence to prevent hospitalizations due to these specific drug interactions.
Contact Us
|
Mail:
|
ISMP Canada 4711 Yonge Street, Suite 501 Toronto, ON M2N 6K8 |
|
Email:
|
webinars@ismp-canada.org |
|
Phone:
|
416–733–3131 ext.0 |
|
Toll Free:
|
1–866–544–7672 ext.0 |
|
Fax:
|
416–733–1146 |
